Category: Latest News
-
Sidus Space shares plunge following public offering pricing
Sidus Space Inc (NASDAQ:SIDU) saw its stock drop sharply by 46.5% in pre-market trading after the space and defense tech firm announced the pricing of a public offering that will notably dilute current shareholders. The company set the price for a best-efforts offering of 7,143,000 shares of Class A common stock at $1.05 each, targeting…
-
Maia Biotechnology shares jump after FDA awards Fast Track status
Maia Biotechnology Inc (AMEX:MAIA) saw its stock surge 11.2% in pre-market trading following the announcement that the U.S. Food and Drug Administration (FDA) granted Fast Track designation to its cancer drug ateganosine. This designation, given for the treatment of non-small cell lung cancer (NSCLC), could speed up the drug’s regulatory review process. Ateganosine is currently…
-
Stereotaxis shares jump after FDA approves robotic mapping catheter
Shares of Stereotaxis (AMEX:STXS) climbed 12% following the U.S. Food and Drug Administration’s (FDA) 510(k) clearance of its MAGiC Sweep catheter, the first-ever robotically navigated high-density electrophysiology mapping catheter worldwide. The MAGiC Sweep catheter marks a major technological breakthrough in the diagnosis and treatment of complex arrhythmias. Featuring 20 electrodes, the device enables fast and…
-
Weekly Outlook: Dow, Nasdaq, and S&P 500 Eye Mag-7 Earnings as August 1 Tariff Deadline Nears
U.S. stock markets ended Friday on a high note, capping a strong week fueled by upbeat corporate earnings and encouraging trade news. The S&P 500 gained 0.40% to close at a new record high of 6,388.64, marking its 14th all-time peak this year. The Nasdaq Composite also reached fresh heights, adding 0.24% to finish at…
-
U.S. LNG Stocks Jump After EU Commits to Massive Fuel Purchases in Landmark Deal
Shares of major U.S. liquefied natural gas (LNG) developers surged on Monday morning following the announcement of a sweeping trade agreement in which the European Union agreed to buy $750 billion worth of LNG from the United States over the next three years. The framework deal, unveiled Sunday, commits the EU to annual purchases of…
-
Provident Financial Misses Q4 Estimates as Profit Drops on Higher Costs, Weaker Fee Income
Provident Financial Holdings, Inc. (NASDAQ:PROV) reported fourth-quarter earnings that missed analyst projections, as a rise in operating costs and a drop in non-interest income led to a 17% decline in net profit compared to the same period a year earlier. For the quarter ending June 30, 2025, the parent of Provident Savings Bank posted net…
-
Revvity Surpasses Q2 Forecasts with Solid Revenue Growth Across Divisions
Revvity, Inc. (NYSE:RVTY) reported stronger-than-expected results for the second quarter, with steady revenue gains across its Life Sciences and Diagnostics segments, despite a complex economic backdrop. The company delivered adjusted earnings per share of $1.18, beating Wall Street expectations of $1.14. Total revenue reached $720 million, exceeding the average analyst forecast of $710.39 million. Compared…
-
Celcuity Shares Double After Landmark Breast Cancer Drug Trial Results
Celcuity Inc. (NASDAQ:CELC) saw its stock soar by more than 100% on Monday following the release of groundbreaking Phase 3 trial data for its experimental breast cancer drug, gedatolisib. The therapy demonstrated unprecedented effectiveness in patients with hormone receptor-positive, HER2-negative advanced breast cancer. According to the company, the combination of gedatolisib with palbociclib and fulvestrant—known…
-
CervoMed Shares Surge After Promising Dementia Drug Trial Results
Shares of CervoMed Inc. (NASDAQ:CRVO) jumped 30% on Monday following the release of new clinical data suggesting that its investigational therapy, neflamapimod, may significantly slow disease progression in patients with dementia with Lewy bodies (DLB). The Boston-based biotech firm unveiled 32-week results from its RewinD-LB trial, indicating that patients who received neflamapimod experienced a 54%…
-
Gold Drops as BofA Cautions on Automated Selling Risk
Gold prices slid on Monday amid warnings from Bank of America that further weakness could set off automatic selling by commodity trading advisors (CTAs). The metal has been facing persistent downside pressure, with prices approaching levels that could activate stop-loss mechanisms used by trend-based trading systems. Bank of America’s analysts believe that many trend-following investors…